Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Siemens Healthineers Ag (SHL.D.DX)

Siemens Healthineers Ag (SHL.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Siemens Healthineers Ag Siemensstr. 3 Forchheim BY 91301 DEU

P: 913-184-3385

Description:

Siemens Healthineers AG is engaged in the fields of diagnostic, therapeutic imaging, laboratory and point of care diagnostics as well as clinical consulting services. The imaging segment products equipment include magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging and ultrasound. The portfolio of the Diagnostics segment includes; immunochemistry, hematology, coagulation, urinalysis, etc. Advanced Therapies segment products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology and surgery. Varian segment provides multi-modality cancer care technologies, solutions and services to oncology departments in hospitals and clinics. It caters and earns revenue from Europe, the Middle East, Africa, China and others.

Key Statistics

Overview:

Market Capitalization, $K 59,798,819
Shares Outstanding, K 1,118,571
Annual Sales, $ 21,680 M
Annual Net Income, $ 1,509 M
Last Quarter Sales, $ 5,435 M
Last Quarter Net Income, $ 426,000 K
% of Institutional Shareholders 12.50%

Growth:

1-Year Return 5.47%
3-Year Return 0.98%
5-Year Return 0.00%
5-Year Revenue Growth 10.05%
5-Year Earnings Growth 1.24%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm 1.63
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 22.39%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 1.76%
Most Recent Dividend 0.950 on 04/19/24
Next Ex-Dividends Date 04/19/24
Dividend Payable Date 04/23/24
Dividend Payout Ratio 0.00%

SHL.D.DX Ratios

Ratio
Price/Earnings ttm 33.03
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 10.23%
Return-on-Assets % 4.02%
Profit Margin % 6.96%
Debt/Equity 0.02
Price/Sales 2.78
Price/Cash Flow 31.45
Price/Book 3.23
Book Value/Share 16.66
Interest Coverage 7.51
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar